EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
44 hedge funds and large institutions have $7.6M invested in Eiger BioPharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
97% less capital invested
Capital invested by funds: $297M → $7.6M (-$290M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
44
Holding in Top 10
–
Calls
$1.25M
Puts
$614K
Top Buyers
| 1 | +$3.58M | |
| 2 | +$332K | |
| 3 | +$207K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$199K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$187K |
Top Sellers
| 1 | -$44M | |
| 2 | -$36.6M | |
| 3 | -$27.4M | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$18.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.4M |